|
|
Efficacy of Continuous Renal Replacement Therapy on Acute Renal Failure and Its Effects on Levels of T Lymphocytes Inflammatory Factors and Serum Electrolytes |
HAN Ruiping, et al |
Wuhan First Hospital, Hubei Wuhan 430000, China |
|
|
Abstract Objective: To observe the efficacy of continuous renal replacement therapy (CRRT) on acute renal failure (ARF) and its effects on levels of T lymphocytes, inflammatory factors and serum electrolytes. Methods: A total of 161 patients with ARF treated in the hospital were randomly divided into observation group (n=81) and control group (n=80) according to simple random sampling. On the basis of conventional treatment, patients in control group were treated with intermittent hemodialysis (IHD), and patients in observation group were administered CRRT. The clinical efficacy of the two groups of patients was compared, and the changes in immune function indicators (CD3+, CD4+, CD8+, CD4+/CD8+), inflammatory factors [interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-8 (IL-8) and tumor necrosis factor-α (TNF-α)], serum electrolytes [potassium (K+), sodium (Na+), chlorine (Cl-)] and renal function indicators [blood urea nitrogen (BUN), serum creatinine (Scr), endogenous creatinine clearance rate (Ccr), β2 microglobulin (β2-MG)] were observed in the two groups before treatment and after 3 months of treatment. Results: The total clinical effective rate of observation group was significantly higher than that of control group (96.3% vs 87.5%) (P<0.05). After 3 months of treatment, the levels of CD3+, CD4+, CD4+/CD8+ and Ccr in the two groups of patients were higher than those before treatment, and the differences before and after treatment between the two groups were statistically significant (P<0.05). The levels of CD8+, IL-1, IL-6 , IL-8, TNF-α, K+, Na+, Cl-, BUN, Scr and β2-MG were lower in the two groups of patients than those before treatment, and the differences before and after treatment were statistically significant between the two groups (P<0.05). Conclusion: CRRT has a significant effect in the treatment of patients with ARF. It can reduce the levels of inflammatory factors, regulate the levels of electrolytes, enhance the body’s immunity, and improve the renal function.
|
|
|
|
|
[1] 李强,苗世敏.连续性肾脏替代治疗与间歇性血液透析治疗在急性肾衰竭中的治疗效果比较[J].中国中西医结合肾病杂志,2018,19(1):70~72. [2] 苏惠娟,陈永强,李红帅,等.连续性血液净化对感染所致急性肾衰患者肾功能炎性因子及免疫功能的影响[J].安徽医学,2019,40(3):86~90. [3] 王海燕.肾脏病学[M].第3版.北京:人民卫生出版社,2008.1934~1937. [4] 王克坤,蒙绪君,韩辉,等.血液透析与连续性血液净化透析治疗急性肾衰竭的疗效及对患者毒素清除率和肾功能指标的影响[J].河北医学,2020,26(5):88~92. [5] 李本通、朱从建、龚军.床旁持续血液滤过联合血液灌流治疗感染性休克患者的效果及对血流动力学和炎性因子的影响[J].广东医学,2020,41(14):71~75. [6] 李培岭,王欣欣,范蕊,等.T淋巴细胞相关细胞因子与儿童慢性免疫性血小板减少症转归的相关性研究[J].中华实用儿科临床杂志,2020,35(3):206~209. [7] 霍洁,唐蔚.重症急性肾衰老年患者接受连续性肾脏替代治疗的临床观察[J].中国医师杂志,2020,22(9):1404~1406. [8] 彭博,孟德志,黄秀峰.连续性肾脏替代疗法治疗重症急性胰腺炎的效果及对炎性介质和凝血功能的影响[J].解放军预防医学杂志,2019,37(5):51~52. [9] 杨婷婷,周瑞祥,姚慧,等.连续性肾脏替代治疗时机选择对脓毒症急性肾损伤患者预后的影响[J].现代仪器与医疗,2019,25(5):11~15. [10] 徐杨,杜惠芬,李克生,等.金标法检测尿β2-MG在肾功能损伤诊断中的临床价值[J].检验医学与临床,2019,16(3):306~307,311. [11] 周爽.血液净化在急性肾损伤治疗中的临床效果及肾功能恢复率的分析[J].中国医药指南,2019,17(32):126~127. |
|
|
|